Skip to content

Author

P. Waghmare

We have 2 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Casein Kinase 1 and CK2 as Therapeutic Targets in Cancer: Molecular Pharmacology, Toxicological Considerations, and Clinical Progress.

Casein kinase 1 (CK1) and casein kinase 2 (CK2) are highly conserved serine/threonine protein kinases that regulate multiple oncogenic signaling pathways involved in cancer progression, metastasis, and therapeutic resistance. Overexpression or dysregulation of CK1 and CK2 has been shown to contribute to the development...

P. Waghmare, A. Chabukswar, K. Raut et al. · 0 citations
Review Open access Jul 2026

Smart Drug Design: AI in Transcriptional Modulation and Clinical Innovation

AI-driven approaches in transcription modulator discovery are highlighted, including in silico target identification, multi-omics integration, and structure–activity optimization, and the importance of explainable AI and personalised therapeutics in advancing precision medicine and next-generation transcription-based d...

A. Pimpale, P. Waghmare, Pallavi Zode et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.